Back to results
US 10,821,164 B2Granted
Peptides for inducing Chagas disease responses
AssigneesSaint Louis University, EpiVax, Inc.
InventorsDaniel Hoft, Chris Eickhoff, Annie De Groot
Life of this patent
Estimating the term…
Abstract
The present disclosure relates to vaccine formulations and their use in treating and preventing Chagas Disease.
Claims16
A method of inducing an immune response in a subject comprising administering to a subject one or more peptides comprising an amino acid sequence selected from the group consisting of SEQ ID NO:
- 1-5 and 7-30, wherein (a) at least one trans-sialidase peptide and one non-trans-sialidase peptide are administered;
- (b) at least one functional trans-sialidase peptide and at least one non-functional trans-sialidase peptide are administered;
- (c) at least one functional trans-sialidase peptide and at least one non-trans-sialidase peptide are administered;
- or (d) at least one non-functional trans-sialidase peptide and at least one non-trans-sialidase peptide are administered.
1 more element
Dependencies are inferred from the claim text.